SEC Form 4 · accession 0001645627-18-000041
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 31, 2018
Accepted (ET)
Aug 3, 2018 · 11:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2018 | P | 1,000 | $0.0298 | A | 25,214,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0299 | A | 25,216,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.03 | A | 25,218,498 | D | |
| Common Stock | Jul 31, 2018 | P | 1,000 | $0.0298 | A | 25,219,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,221,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,223,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.03 | A | 25,228,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,230,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.03 | A | 25,232,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,234,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.03 | A | 25,236,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,238,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0298 | A | 25,240,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0297 | A | 25,242,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0289 | A | 25,244,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0289 | A | 25,246,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0289 | A | 25,248,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0297 | A | 25,253,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0297 | A | 25,255,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0297 | A | 25,260,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0308 | A | 25,262,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0308 | A | 25,264,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0308 | A | 25,266,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0309 | A | 25,271,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0309 | A | 25,273,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0309 | A | 25,278,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0309 | A | 25,283,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0309 | A | 25,285,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0309 | A | 25,290,498 | D | |
| Common Stock | Jul 31, 2018 | P | 5,000 | $0.0312 | A | 25,295,498 | D |
Table II — derivative securities
No Table II lines on this filing.